Cardiovascular Pharmacology: An Update and Anesthesia Considerations

Camellia Asgarian; Henry Liu; Alan D Kaye

doi:10.1016/j.anclin.2017.01.013

Cardiovascular Pharmacology: An Update and Anesthesia Considerations

Anesthesiol Clin. 2017 Jun;35(2):273-284. doi: 10.1016/j.anclin.2017.01.013. Epub 2017 Apr 14.

Authors

Camellia Asgarian¹, Henry Liu², Alan D Kaye³

Affiliations

¹ Department of Anesthesiology, LSU School of Medicine, T6M5, 1542 Tulane Avenue, Room 656, New Orleans, LA 70112, USA. Electronic address: casgar@lsuhsc.edu.
² Department of Anesthesiology & Perioperative Medicine, Hahnemann University Hospital, Drexel University College of Medicine, 245 North 15th Street, MS 310, Philadelphia, PA 19102, USA.
³ Department of Anesthesiology, LSU School of Medicine, T6M5, 1542 Tulane Avenue, Room 656, New Orleans, LA 70112, USA.

PMID: 28526148
DOI: 10.1016/j.anclin.2017.01.013

Abstract

Cardiovascular disease remains a leading cause of morbidity and mortality worldwide. The development of therapeutic agents for the treatment of cardiovascular diseases has always been a priority because of the huge potential market for these drugs. These medications should be part of the anesthesiologist's armamentarium because the typical surgical patient is older and has more comorbidities than in the past. This article reviews commonly used cardiovascular medications that are important in managing patients with unstable hemodynamics.

Keywords: Anesthesia; Cardiovascular; Hemodynamic instability; Pharmacology.

Publication types

Review

MeSH terms

Anesthesia*
Blood Pressure / physiology
Cardiovascular Agents / pharmacology*
Cardiovascular Agents / therapeutic use
Cardiovascular Diseases / drug therapy*
Heart Rate / physiology
Hemodynamics*
Humans

Substances

Cardiovascular Agents